logo
  

Moderna Files For Authorization Of COVID-19 Vaccine In Canada To Include Children Ages 6-11 Yrs

Moderna Inc. (MRNA) said Wednesday that it has submitted for authorization with Health Canada for the evaluation of a 50 µg two-dose series of SPIKEVAX (elasomeran mRNA vaccine) in children ages 6 to 11 years.

The company noted that the phase 2/3 "KidCOVE" study of SPIKEVAX in pediatric population ages 6 months to under 12 years is ongoing. Moderna recently shared new data from the KidCOVE study in children ages 6 years to 11 years. Vaccine efficacy of 100% using the Phase 3 COVE study primary case definition for COVID-19 was observed two weeks after the first dose of SPIKEVAX at the 50 µg dose level.

In September 16, 2021, Health Canada approved the New Drug Submission (NDS-CV) for SPIKEVAX for active immunization to prevent COVID-19 in individuals 12 years of age and older.

On November 12, 2021 Health Canada authorized the use of a 50 µg booster dose for individuals aged 18 and older administered at least six months after completion of the primary series.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Omni-channel fashion retailer Macy's, Inc. (M) reported Thursday a first-quarter net income of $286 million or $0.98 per share, sharply higher than $103 million or $0.32 per share in the prior-year quarter. Excluding items, adjusted net income for the quarter was $315 million or $1.08 per share, compared... Richmond, Utah-based Casper's Ice Cream is recalling its 56 ounce tubs of "Red Button Vintage Creamery Canadian Vanilla Ice Cream" due to undeclared allergen, the U.S. Food and Drug Administration said. According to the agency, a limited number of the product were mispackaged with Burnt Almond Fudge Ice Cream containing undeclared almonds. Teva Pharmaceuticals USA, Inc. has recalled one lot of platelet-reducing drug Anagrelide in the form of capsules due to dissolution test failure detected during routine stability testing, the U.S. Food and Drug Administration, or FDA, said in a statement.
Follow RTT